Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

The PCSK9 inhibitors are among the most effective and expensive lipid-lowering drugs. They reduce LDL cholesterol by 50-72% and lipoprotein (a) by 20-25%. It is difficult to assess their clinical benefit
Imran et al. 2023 PLoS One 18: e0295359…

References (Sources)

Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis
Imran et al. 2023 PLoS One 18: e0295359

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat